References

  1. Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W. Non-invasive genotyping foetal Kell blood group (KEL1) using cell-free DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenatal Diagnosis. 2008; 28(3): 203-208. PubMed | Google Scholar

  2. Lin M, Wang CL, Chen FS, Ho LH. Fatal haemolytic transfusion reaction due to anti-Ku in a K null patient. Immunohematology. 2003; 19(1):19-21. PubMed | Google Scholar

  3. Dean L. Blood Groups and Red Cell Antigens. Bethesda. National Center for Biotechnology Information (US); 2005. PubMed | Google Scholar

  4. Dean L. The Kell blood group - Blood Groups and Red Cell Antigens. NCBI Bookshelf. National Center for Biotechnology Information - United States National Institutes of Health. Retrieved 2009-05-04. PubMed | Google Scholar

  5. Mohandas N, Narla A. Blood group antigens in health and disease. Current Opinion in Haematology. 2005; 12(12):135-140. PubMed | Google Scholar

  6. Wagner T, Resch B, Reiterer F, Gassner C, Lanzer G. Pancytopenia due to suppressed hematopoiesis in a case of fatal hemolytic disease of the newborn associated with anti-K supported by molecular K1 typing. Journal of Pediatric Hematology Oncology. 2004; 26(1):13-15. PubMed | Google Scholar

  7. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. Second ed. 2004, New York: Elsevier Academic Press. Google Scholar

  8. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in foetal alloimmune anaemia. New England Journal of Medicine. 1998; 338(12):798-803. PubMed | Google Scholar

  9. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol. 1994; 171(1):247-252. PubMed | Google Scholar

  10. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med. 1998; 338(12):798-803. PubMed | Google Scholar

  11. Daniels G, Hadley A, Green CA. Causes of foetal anemia in hemolytic disease due to anti-K. Transfusion. 2003; 43(1):115-116. PubMed | Google Scholar

  12. National Population Commission (NPC). National Census Figures, Abuja, Nigeria. 2007. Google Scholar

  13. Lamba DS, Kaur R, Basu S. Clinically Significant Minor Blood Group Antigens amongst North Indian Donor Population. Advances in Hematology. 2013; 2013: 215454. PubMed | Google Scholar

  14. Chaudhary RK, Shukla JS, Ray V. Minor red cell antigens in North India blood donor population. Indian Journal of Haematology and Blood Transfusion. 2003; 21:34-35. PubMed | Google Scholar

  15. Ugboma HA, Nwauche CA. Kell blood group antigen in Port Harcourt, Nigeria-a pilot study. Port Harcourt Medical Journal. 2009; 4(2): ISSN 0795-3038. PubMed | Google Scholar

  16. Thakral B, Saluja K, Sharma RR, Marwaha N . Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis and Lutheran) in Northern India blood donors. Transfusion and Apheresis Science. 2010; 43 (1):17-22. PubMed | Google Scholar

  17. Chan A, Wong HF, Chui CH, Wong L, Cheng G. The impact of a gel system on routine work in a general hospital blood bank. Immunohaematology. 1996; 12:30-32. PubMed | Google Scholar

  18. Nathalang O, Kuvanont S, Punyaprasiddi P, Tasaniyanonda C, Sriphaisal T. A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test. Southeast Asian Journal of Tropical Medicine and Public Health. 2001; 32:204-207. PubMed | Google Scholar

  19. Redman CM, Russo D, Lee S. Kell, Kx and the McLeod syndrome. Baillière's Clinical Haematology. 1999; 12 (4): 621-635. PubMed | Google Scholar

  20. Makroo RN, Bhatia A, Gupta R, Phillip J . Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian Journal of Medical Research. 2013; 137(3):521-526. PubMed | Google Scholar

  21. Mohamed S, Muna I. Characterisation of Rh and other blood group systems amongst the Maldivian blood donors. Medical Journal of Malaysia. 2013; 68(5):393-396. PubMed | Google Scholar

  22. Kahar MA, Patel RD .Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in blood donors of south Gujarat, India. Asian Journal of Transfusion Science. 2014; 8(1):51-55. PubMed | Google Scholar

  23. Lin-Chu M, Broadberry RE, Chang FJ. The distribution of blood group antigens and alloantibodies among Chinese in Taiwan. Transfusion. 1988; 28(4):350-352. PubMed | Google Scholar

  24. Blavy G, Thiam D, Diakhate L. The Kell system in Senegal: phenotype and gene frequencies. International Journal of Anthropology. 1987; 2(1): 75-76. PubMed | Google Scholar

  25. Rahman M. Incidence of important blood groups in Bangladesh. Bangladesh Medical Research Council Bulletin. 1975; 1(1):60-63. PubMed | Google Scholar

  26. Makarovska-Bojadzieva T, Blagoevska M, Kolevski P, Kostovska S. Optimal blood grouping and antibody screening for safe transfusion. Prilozi. 2009; 30(1):119-128. PubMed | Google Scholar

  27. Westhoff CM, Reid ME. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology. 2004; 20(1):37-49. PubMed | Google Scholar

  28. Lee S, Russo D, Redman CM. Review of the Kell blood group system: Kell and XK membrane proteins. Seminar in Hematology. 2000; 37(2):113-121. PubMed | Google Scholar

  29. Jeremiah ZA, Mordi A, Buseri FI, Adias TC. Frequencies of maternal red cell alloantibodies in Port Harcourt, Nigeria. Asian Journal of Transfusion Science. 2011; 5(1):39-41. PubMed | Google Scholar

  30. Shah M, Shah FY, Shah FY. Incidence of Kell blood group in Kashmiri population attending blood bank SKIMS as donors. Annals of Tropical Medicine and Public Health. 2013; 6(3):183-187. PubMed | Google Scholar

  31. Branch DR. Solving the dilemma of prevention of red cell alloimmunization. Immunotherapy. 2002; 4(9):903-905. PubMed | Google Scholar

  32. Natukunda B, Schonewille H, van de Watering L, Brand A. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sanguine. 2010; 98(2):167-171. PubMed | Google Scholar

  33. Zimring JC, Spitalnik SL, Roback JD, Hillyer CD. Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion.2007; 47(12):2189-196. PubMed | Google Scholar

  34. Moise KJ Jr. Non-anti-D antibodies in red-cell alloimmunization. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2000; 92(1):75-81. PubMed | Google Scholar

  35. Hadley AG. In vitro a comparison of test for predicting the severity of haemolytic disease of the foetus and newborn. Vox Sanguine. 1998; 74(suppl 2): 375-383. PubMed | Google Scholar

  36. Malhotra S, Kaur G, Basu S, Kaur R, Jindal G. Alloimmunization to Kell blood group system antigen owing to unmatched blood transfusion in a resource-poor setting. Immunohematology. 2002; 28(2):45-48. PubMed | Google Scholar

  37. Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008; 48(5):941-952. PubMed | Google Scholar

  38. Azarkeivan A, Ansari S, Ahmadi MH, Hajibeigy B, Maghsudlu M, Nasizadeh S, Shaigan M, Toolabi A, Salahmand M. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatric Hematology and Oncology. 2011; 28(6):479-485. PubMed | Google Scholar

  39. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002; 42(6):684-690. PubMed | Google Scholar

  40. Gariod S, Brossard Y, Poissonnier MH, Vuilliez B, Deutsch V, Jouk PS, Pons JC. Kell alloimmunization in pregnancy. Journal of Gynecology, Obstetrics, Biology and Reproduction. 2004; 33(7):637-648. PubMed | Google Scholar

  41. Liu Z, Zeng R, Chen Q, Li M, Shi GY, Wei P, Huang CY, Tang RC, Sun J, Zhang XG. Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han. Chin Med J (Engl). 2012; 125(6):1076-81. PubMed | Google Scholar

  42. van Wamelen DJ, Klumper FJ, de Haas M, Meerman RH, van Kamp IL, Oepkes D. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstetrics and Gynecology. 2007; 109(5):1093-1098. PubMed | Google Scholar

  43. Ahaded A, Brossard Y, Debbia M, Lambin P. Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA. Transfusion. 2000; 40(10):1239-45. PubMed | Google Scholar

  44. Santiago JC, Ramos-Corpas D, Oyonarte S, Montoya F. Current clinical management of anti-Kell alloimmunization in pregnancy. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2008; 136(2):151-154. PubMed | Google Scholar

  45. Finning K, Martin P, Summers J, Daniels G. Foetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free foetal DNA in maternal plasma. Transfusion. 2007; 47(11): 2126-2133. PubMed | Google Scholar

  46. Poole J, Nicole W, Hustinx H, Taleghani BM, Martin P, Finning K, Crew VK, Green C, Bromilow I, Daniels G. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen. Transfusion. 2006; 46(11): 1879-1885. PubMed | Google Scholar